Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FY8PW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,166
Award facts
- Contract value 100% obligated
- $42,166.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,166.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability to meet procurement requirements through open competition, with delivery orders typically structured as firm fixed-price arrangements. This particular award for Repatha, a prescription medication used for cholesterol management, reflects the company's ongoing role as a primary pharmaceutical vendor supporting the Defense Health Agency and other federal healthcare customers through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26FY8PW?
SPE2DR26FY8PW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FY8PW worth?
The government has obligated $42,166 on SPE2DR26FY8PW.
Is contract SPE2DR26FY8PW an order under another contract?
Yes. SPE2DR26FY8PW is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8PW competed?
The extent of competition for SPE2DR26FY8PW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award